Stockreport

Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Company AnnouncementGenmab to acquire ProfoundBio for USD 1.8 billion in cashAcquisition will give Genmab worldwide rights to three candidates in clinical development, i [Read more]